Proliferative scarring

Surgical Clinics of North America

Volumn 83, Issue 3, 2003, Pages 557-569

  Robson, Martin C ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPIONITRILE; ALPHA2B INTERFERON; COLCHICINE; COLLAGEN; CORTICOSTEROID; CYTOKINE; DECORIN; MANNOSE 6 PHOSPHATE; NEUTRALIZING ANTIBODY; PENICILLAMINE; SILICONE; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ANGIOGENESIS; BLOOD CLOTTING; BURN SCAR; CELL PROLIFERATION; DUPUYTREN CONTRACTURE; EXTRACELLULAR MATRIX; HUMAN; HYPERTROPHIC SCAR; HYPOXEMIA; INFLAMMATION; KELOID; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ROSACEA; SCAR FORMATION; SKIN FIBROBLAST; WOUND CONTRACTION; WOUND HEALING;

EID: 0038174860     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(02)00197-4     Document Type: Review

References (48)

1. Robson MC. Growth factors as wound healing agents. Curr Opin Biotechnol 1991;2:863-7.
2. Robson MC, Stenberg BD, Heggers JP. Wound healing alterations caused by infection. Clin Plast Surg 1990;17:485-92.
3. Clark RAF. Biology of dermal wound repair. Dermatol Clin 1993;11:647-66.
4. Robson MC, Steed DL, Franz MG. Wound healing: biologic features and approaches to maximize healing trajectories. Curr Probl Surg 2001;38:61-140.
5. Hunt TK, Hopf HW. Wound healing and wound infections: what surgeons and anesthesiologists can do. Surg Clin N Am 1997;77:587-606.
6. Cuono CB. Scars and keloids. In: Jurkiewicz MJ, Mathes SJ, Krizek TJ, Ariyan S, editors. Plastic surgery: principles and practice, vol. 2. St Louis: Mosby; 1990. p. 1411-28.
7. Linares HA. Hypertrophic healing: controversies and etiopathogenic review. In: Carvajal HF, Parks DH, editors. Burns in children: pediatric burn management. Chicago: Year Book Medical Publishers; 1988. p. 348-62.
8. Robson MC, Barnett RA, Leitch IOW, et al. Prevention and treatment of postburn scars and contracture. World J Surg 1992;16:87-96.
9. Adzick NS, Lorenz P. Cells, matrix, growth factors, and the surgeon: the biology of scarless fetal wound repair. Ann Surg 1994;220:10-8.
10. Ferguson MWJ, Howarth GF. Marsupial models of scarless wound healing. In: Adzick NS, Longaker MT, editors. Fetal wound healing. New York: Elsevier Scientific Press; 1992. p. 95-124.
11. Mast BA, Nelson JM, Krummel TM. Tissue repair in the mammalian fetus. In: Cohen IK, Diegelmann RF, Lindblad WJ, editors. Wound healing: biochemical and clinical aspects. Philadelphia: WB Saunders; 1992. p. 326-41.
12. Murray JC, Pinnell SR. Keloids and excessive dermal scarring. In: Cohen IK, Diegelmann RF, Lindblad WJ, editors. Wound healing: biochemical and clinical aspects. Philadelphia: WB Saunders; 1992. p. 500-9.
13. Polo M, Ko F, Busillo F, et al. 1997 Moyer Award: cytokine production in patients with hypertrophic burn scars. J Burn Care Rehabil 1997;18:477-82.
14. Ketchum LD, Cohen IK, Masters FW. Hypertropic scars and keloids: a collective review. Plast Reconstr Surg 1974;53:140-54.
15. Smith P, Mosiello G, Deluca L, et al. TGFβ2 activates proliferative scar fibroblasts. J Surg Res 1999;82:319-23.
16. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;321:1286-92.
17. O'Kane S, Ferguson MWJ. Transforming growth factor-βs and wound healing. Int J Biochem Cell Biol 1997;29:63-78.
18. Roberts AB. Transforming growth factor β: activity and efficacy in animal models of wound healing. Wound Rep Regen 1996;3:408-18.
19. Shah M, Foreman DM, Ferguson MW. Neutralization of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108:985-1002.
20. Wang X, Smith P, Pu LLQ, et al. Exogenous growth factor β2 modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats. J Surg Res 1999;87:194-200.
21. Cox DA. Transforming growth factor beta-3. Cell Biol Int 1995;19:357-70.
22. Lee TY, Chin GS, Kim WGH, et al. Expression of transforming growth factor beta 1,2, and 3 proteins in keloids. Ann Plast Surg 1999;43:179-84.
23. Pu LLQ, Smith PD, Payne WG, et al. Overexpression of transforming growth factor beta-2 and its receptor in rhinophyma: an alternative mechanism of pathobiology. Ann Plast Surg 2000;45:515-9.
24. Younai S, Nichter LS, Wellisz T, et al. Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts. Ann Plast Surg 1994;33:148-51.
25. Younai S, Venters G, Vu S, et al. Role of growth factors in scar contraction: an in vitro analysis. Ann Plast Surg 1996;36:495-501.
26. Kuhn A, Singh S, Smith PD, et al. Periprosthetic breast capsules contain the fibrogenic cytokines TGF-β1 and TGF-β2, suggesting new treatment approaches. Ann Plast Surg 2000;44:387-91.
27. Kuhn MA, Payne WG, Kierney PC, et al. Cytokine manipulation of explanted Dupuytren's affected human palmar fascia. Int J Surg Invest 2001;2:443-56.
28. Polo M, Kim Y-J, Kucukcelebi A, et al. An in vivo model of human proliferative scar. J Surg Res 1998;74:187-95.
29. Polo M, Smith PD, Kim Y-J, et al. Effect of TGF-β2 on proliferative scar fibroblast cell kinetics. Ann Plast Surg 1999;43:185-90.
30. Wasserman RJ, Polo M, Smith P, et al. Differential production of apoptosis-modulating proteins in patients with hypertrophic burn scar. J Surg Res 1998;75:74-80.
31. Datubo-Brown DD. Keloids: a review of the literature. Br J Plast Surg 1990;43:70-7.
32. Lawrence WT. In search of the optimal treatment of keloids: report of a series and review of the literature. Ann Plast Surg 1991;27:164-78.
33. Ahn ST, Monafo WW, Mustoe TA. Topical silicone gel: a new treatment for hypertrophic scars. Surgery 1989;106:781-7.
34. Ahn ST, Monafo WW, Mustoe TA. Topical silicone gel for the prevention and treatment of hypertrophic scar. Arch Surg 1991;126:499-504.
35. Mercer NGS. Silicone gel in the treatment of keloid scars. Br J Plast 1989;42:83-7.
36. Kuhn MA, Moffitt MR, Smith PD, et al. Silicone sheeting decreases fibroblast activity and downregulates TGFβ2 in hypertrophic scar model. Int J Surg Invest 2001;2:467-74.
37. Peacock EE. Pharmacologic control of surface scarring in human beings. Ann Surg 1981;193:592-7.
38. Shah M, Foreman DM, Ferguson MWJ. Control of scarring in adult wounds by neutralizing antibody to transforming growth factor β. Lancet 1992;339:213-4.
39. Tredget EE, Shankowsky HA, Pannu R, et al. Transforming growth factor-β in thermally injured patients with hypertrophic scars: effect of interferon α-2b. Plast Reconstr Surg 1998;102:1317-30.
40. McCallion RL, Ferguson MWJ. Fetal wound healing and the development of antiscarring therapies for adult wound healing. In: Clark RAF, editors. The molecular and cellular biology of wound repair. New York: Plenum Press; 1996. p. 561-600.
41. Mancoll JS, Zhao J, McCauley RL, et al. The inhibitory effect of tamoxifen on keloid fibroblasts. Surg Forum 1996;47:718-20.
42. Hu D, Hughes MA, Cherry GW. Topical tamoxifen - a potential therapeutic regime in treating excessive dermal scarring? Br J Plast Surg 1998;51:462-9.
43. Chau D, Mancoll JS, Lee S, et al. Tamoxifen downregulates TGF-β production in keloid fibroblasts. Ann Plast Surg 1998;40:490-3.
44. Kuhn MA, Wang X, Payne WG, et al. Tamoxifen decreases fibroblast function and downregulates TGF-β2 in Dupuytren's affected palmar fascia. J Surg Res 2002;103:146-52.
45. Danielson KG, Baribault H, Holmes DF, et al. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997;136:729-43.
46. Scott PG, Dodd CM, Ghahary A, et al. Fibroblasts from post-burn hypertrophic scar tissue synthesize less decorin than normal dermal fibroblasts. Clin Sci 1998;94:541-7.
47. Hildebrand A, Romaris M, Rasmussen LM, et al. Interaction of the small interstitial proteoglycans biglycan, decorin, and fibromodulin with transforming growth factor beta. Biochem J 1994;302:527-34.
48. Logan A, Berry M, Gonzalez M, et al. Effects of transforming growth factor-β1 on scar production in the injured central nervous system of the rat. Eur J Neurosci 1994;6:355-63.